BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25331383)

  • 1. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
    Miravitlles M; Worth H; Soler Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    Respir Res; 2014 Oct; 15(1):122. PubMed ID: 25331383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study.
    Scichilone N; Antonelli Incalzi R; Blasi F; Schino P; Cuttitta G; Zullo A; Ori A; Canonica GW;
    BMC Pulm Med; 2019 Sep; 19(1):171. PubMed ID: 31500607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Miravitlles M; Menezes A; López Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Wehrmeister FC; Surmont F; Montes de Oca M
    Respir Med; 2018 Jan; 134():62-69. PubMed ID: 29413510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain.
    Soler-Cataluña JJ; Sauleda J; Valdés L; Marín P; Agüero R; Pérez M; Miravitlles M
    Arch Bronconeumol; 2016 Jun; 52(6):308-15. PubMed ID: 26774700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of thoracic pain in patients with chronic obstructive pulmonary disease and relationship with patient characteristics: a cross-sectional observational study.
    Janssen DJ; Wouters EF; Parra YL; Stakenborg K; Franssen FM
    BMC Pulm Med; 2016 Apr; 16():47. PubMed ID: 27052199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of night-time symptoms in COPD: a real-world study in five European countries.
    Price D; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():595-603. PubMed ID: 24348032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD.
    Muñoz A; Small M; Wood R; Ribera A; Nuevo J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1557-1568. PubMed ID: 29805254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and depression among dairy farmers: the impact of COPD.
    Guillien A; Laurent L; Soumagne T; Puyraveau M; Laplante JJ; Andujar P; Annesi-Maesano I; Roche N; Degano B; Dalphin JC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1-9. PubMed ID: 29296078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variability of respiratory symptoms and associated factors in COPD.
    Miravitlles M; Izquierdo JL; Esquinas C; Pérez M; Calle M; López-Campos JL; Rodríguez González-Moro JM; Casanova C; Esteban C; de Lucas P
    Respir Med; 2017 Aug; 129():165-172. PubMed ID: 28732827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
    Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD.
    Ding B; Small M; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():589-599. PubMed ID: 28243077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study.
    Mihaltan F; Adir Y; Antczak A; Porpodis K; Radulovic V; Pires N; de Vries GJ; Horner A; De Bontridder S; Chen Y; Shavit A; Alecu S; Adamek L
    Respir Res; 2019 May; 20(1):89. PubMed ID: 31088560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
    Marin JM; Beeh KM; Clemens A; Castellani W; Schaper L; Saralaya D; Gunstone A; Casamor R; Kostikas K; Aalamian-Mattheis M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1425-34. PubMed ID: 27418815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of illness acceptance by patients with COPD and the prevalence of depression and anxiety in COPD.
    Uchmanowicz I; Jankowska-Polanska B; Motowidlo U; Uchmanowicz B; Chabowski M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():963-70. PubMed ID: 27274217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study.
    Beier J; Mroz R; Kirsten AM; Chuecos F; Gil EG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1731-1740. PubMed ID: 28652725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients.
    Morélot-Panzini C; Gilet H; Aguilaniu B; Devillier P; Didier A; Perez T; Pignier C; Arnould B; Similowski T
    Eur Respir J; 2016 Jun; 47(6):1668-79. PubMed ID: 27076585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.